genedrive (LON:GDR) Shares Down 1.3% – Here’s What Happened

genedrive plc (LON:GDR) shares were down 1.3% during trading on Friday. The company traded as low as GBX 0.88 and last traded at GBX 0.89. Approximately 1,913,919 shares were traded during mid-day trading, a decline of 63% from the average session volume of 5,111,255 shares. The stock had previously closed at GBX 0.90.

genedrive Stock Performance

The company has a debt-to-equity ratio of -120.48, a quick ratio of 5.52 and a current ratio of 0.99. The stock’s 50-day moving average is GBX 1.12 and its 200 day moving average is GBX 1.12. The firm has a market cap of £14.26 million, a P/E ratio of -1.12 and a beta of 1.00.

Insider Activity

In other genedrive news, insider Gino Miele purchased 700,000 shares of the stock in a transaction on Friday, August 28th. The stock was bought at an average cost of GBX 1 per share, for a total transaction of £7,000. 28.09% of the stock is owned by company insiders.

genedrive Company Profile

genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.